← Back

Wire · regulatory

Panel recommends measures to support commercialisation of domestic MedTech

Published

29 August 2026

Topic

regulatory

Sectors

Medtech

Geography

India

Source

Read at pharmabiz.com

Verified

Fusion42 · 30 August 2026 · Fusion42 review

The Parliamentary Standing Committee on Health and Family Welfare recommends scaling up the MedTech Mitra platform and streamlining regulatory approval timelines to accelerate commercialisation of domestic medical technologies. The report emphasises reforms to reduce manufacturing license timelines and enhance digital regulatory pathways to promote affordability and accessibility in healthcare.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

You face faster regulatory approvals for medical devices in India as licensing timelines shrink and digital tools improve. Medtech founders can push for quicker product launches and scale local manufacturing to compete with imports.

Coverage

1 source · 29 Aug 2026

Related on Wire

Topics

Medtechmedtechregulatory-reformaffordabilitydomestic-manufacturinghealthcare-access